Page last updated: 2024-10-22

theophylline and Anti-Phospholipid Antibody Syndrome

theophylline has been researched along with Anti-Phospholipid Antibody Syndrome in 1 studies

Research Excerpts

ExcerptRelevanceReference
"To investigate whether antiplatelet agents, dilazep and dipyridamole, inhibit tissue factor (TF) expression on monocytes induced by IgG from patients with antiphospholipid syndrome (APS)."7.72Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome. ( Zhou, H, 2004)
"To investigate whether antiplatelet agents, dilazep and dipyridamole, inhibit tissue factor (TF) expression on monocytes induced by IgG from patients with antiphospholipid syndrome (APS)."3.72Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome. ( Zhou, H, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhou, H1

Other Studies

1 other study available for theophylline and Anti-Phospholipid Antibody Syndrome

ArticleYear
Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome.
    Acta pharmacologica Sinica, 2004, Volume: 25, Issue:10

    Topics: Adrenergic Antagonists; Antiphospholipid Syndrome; Cell Separation; Dilazep; Dipyridamole; Gene Expr

2004